Published in J Exp Med on April 01, 1969
Suppression of the immune response by microorganisms. Bacteriol Rev (1975) 2.53
Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun (1978) 2.35
Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic fever. J Clin Invest (1974) 1.31
Ultrastructural, immunologic, and functional studies on Sézary cells: a neoplastic variant of thymus-derived (T) lymphocytes. Proc Natl Acad Sci U S A (1974) 1.24
Purification of a monocytosis-producing activity from Listeria monocytogenes. Infect Immun (1977) 0.95
Impaired lymphocyte stimulation by some streptococcal antigens in patients with recurrent aphthous stomatitis and rheumatic heart disease. Clin Exp Immunol (1970) 0.93
Effect of streptolysin S on human and mouse T and B lymphocytes. Infect Immun (1977) 0.93
Isolation by electrofocusing of two lymphocyte mitogens produced by Staphylococcus aureus. Infect Immun (1972) 0.87
Group A streptococcal pyrogenic exotoxin (scarlet fever toxin) type A and blastogen A are the same protein. Infect Immun (1989) 0.86
Bacterial lipopolysaccharides induce in vitro degradation of cartilage matrix through chondrocyte activation. J Clin Invest (1983) 0.86
Suppression of adjuvant disease by bacterial extracellular products. Ann Rheum Dis (1972) 0.78
Recent advances in rheumatic fever control and future prospect: a WHO memorandum. Bull World Health Organ (1978) 0.75
The mechanism of experimental arthritis produced by streptolysin S. Proc R Soc Med (1971) 0.75
Lymphocyte stimulation response in horses against phytohaemagglutinin and M protein of Streptococcus equi using whole blood. Can J Comp Med (1982) 0.75
In vivo and in vitro antiinflammatory and immunoregulating properties of streptococcal mitogen: effects on adjuvant disease in the rat, on homograft rejection in the mouse, and on the appearance of Ia antigens on human T lymphocytes. Agents Actions (1986) 0.75
[Recent progress in the fight against acute arthritic rheumatism and future perspectives: WHO Memorandum]. Bull World Health Organ (1979) 0.75
Immunosuppressive activity of BCG: effects of adjuvant disease, lymphocyte subpopulations, and homing of thoracic duct cells in rats. Infect Immun (1979) 0.75
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
AN IN VITRO SYSTEM FOR THE STUDY OF THE MECHANISM OF ANTIGENIC STIMULATION IN THE SECONDARY RESPONSE. Immunology (1964) 5.36
Relationship of in vitro lymphocyte transformation to delayed hypersensitivity in guinea pigs and man. Fed Proc (1990) 4.31
EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Nature (1963) 3.65
LYMPHOCYTE INTERACTION: A POTENTIAL HISTOCOMPATIBILITY TEST IN VITRO. Science (1964) 3.49
Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science (1965) 3.40
The effect of nucleic acids and of carbohydrates on the formation of streptolysin. J Exp Med (1948) 3.17
Studies on human peripheral blood lymphocytes in vitro. II. Morphological and biochemical studies on the transformation of lymphocytes by pokeweed mitogen. J Exp Med (1966) 2.63
THE ACTIVATION OF HUMAN PERIPHERAL LYMPHOCYTES BY PRODUCTS OF STAPHYLOCOCCI. Br J Haematol (1965) 2.18
Cytotoxic action of stimulated lymphocytes on allogenic and autologous erythrocytes. Science (1968) 2.17
Host-parasite relationships among group A streptococci. IV. Suppression of antibody response by streptococcal pyrogenic exotoxin. J Bacteriol (1968) 2.16
THE ACTION OF STREPTOLYSIN S ON PERIPHERAL LYMPHOCYTES OF NORMAL SUBJECTS AND PATIENTS WITH ACUTE RHEUMATIC FEVER. Proc Natl Acad Sci U S A (1964) 2.13
Cytolytic toxins of bacterial origin. The nature and properties of cytolytic proteins are discussed with emphasis on staphylococcal alpha-toxin. Science (1968) 2.03
MITOGENIC ACTIVITY IN PHYTOLACCA AMERICANA (POKEWEED). Lancet (1964) 2.03
Stabilization of streptolysin S by potassium ions. J Exp Med (1950) 1.86
Radioactive method for the measurement of lymphocyte transformation in vitrol. Lancet (1965) 1.68
The nature of antistreptolysin S in the sera of man and of other species; antistreptolysin titres in normal and diseased states. Br J Exp Pathol (1949) 1.62
OXYGEN-STABLE HEMOLYSINS OF GROUP A STREPTOCOCCI. 3. THE RELATIONSHIP OF THE CELL-BOUND HOMOLYSIN TO STREPTOLYSIN S. J Exp Med (1965) 1.59
Inhibition of streptolysin S by the serum of patients with rheumatic fever and acute streptococcal pharyngitis. J Clin Invest (1950) 1.47
Specific role of each human leukocyte type in viral infections. I. Monocyte as host cell for vesicular stomatitis virus replication in vitro. J Virol (1967) 1.37
Immunosuppressant from group A streptococci. Science (1968) 1.23
OXYGEN-STABLE HEMOLYSINS OF BETA-HEMOLYTIC STREPTOCOCCI. Ergeb Mikrobiol Immunitatsforsch Exp Ther (1964) 1.20
Stimulation of interferon production in human lymphocytes by mitogens. Proc Soc Exp Biol Med (1967) 1.09
EFFECT OF CYSTEINE ON FORMATION OF STREPTOLYSIN S BY GROUP A STREPTOCOCCI. Proc Soc Exp Biol Med (1964) 1.02
High lymphocyte transformation with non-haemolytic streptococcal product. Nature (1968) 0.91
Suppression of antibody production by phytohaemagglutinin. Nature (1967) 0.90
MISSING LINKS IN THE STREPTOCOCCAL CHAIN LEADING TO RHEUMATIC FEVER. Circulation (1964) 0.80
Interferon's promise in clinical medicine. Fact or fancy? Am J Med (1967) 0.79
Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology (1973) 2.07
Effect of prostaglandin E 1 on adjuvant arthritis. Nature (1971) 2.02
Mechanisms underlying binding of immune complexes to macrophages. J Exp Med (1971) 2.00
Predicting patient satisfaction from physicians' nonverbal communication skills. Med Care (1980) 1.95
Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol (2000) 1.77
Studies on the lymphocyte 5'-nucleotidase in chronic lymphocytic leukemia, infectious mononucleosis, normal subpopulations, and phytohemagglutinin-stimulated cells. Cancer Res (1974) 1.74
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet (2005) 1.63
Gouty arthritis following gunshot wound: a case report. N Y State J Med (1992) 1.59
Rheumatic fever in children. Am Heart J (1980) 1.47
Cardiopulmonary resuscitation in patients with the acquired immunodeficiency syndrome. A prospective study. Arch Intern Med (1988) 1.46
Thromboxane A2 regulates protein synthesis of cultured human mesangial cells. J Lab Clin Med (1992) 1.43
Risk of rheumatic-fever recurrences after streptococcal infections. Prospective study of clinical and social factors. N Engl J Med (1971) 1.42
Competence of thoracic duct cells in the transfer of adjuvant disease and delayed hypersensitivity. Evidence that mycobacterial components are required for the successful transfer of the disease. Cell Immunol (1972) 1.42
Natural history of rheumatic aortic regurgitation. Criteria predictive of death, congestive heart failure, and angina in young patients. Circulation (1971) 1.41
Living wills. Lancet (1994) 1.39
Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations. J Clin Invest (1976) 1.25
Ultrastructural, immunologic, and functional studies on Sézary cells: a neoplastic variant of thymus-derived (T) lymphocytes. Proc Natl Acad Sci U S A (1974) 1.24
Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am J Med (1989) 1.20
Lymphocyte mitogens of staphylococcal origin. Ann N Y Acad Sci (1974) 1.19
Rheumatic fever in siblings. Similarity of its clinical manifestations. N Engl J Med (1968) 1.18
Prostaglandin E 1 as a regulator of lymphocyte function. Selective action on B lymphocytes and synergy with procarbazine in depression of immune responses. Cell Immunol (1973) 1.15
Factors influencing recurrent rheumatic fever. Annu Rev Med (1967) 1.11
High Staphylococcus aureus nasal carriage rate in patients with acquired immunodeficiency syndrome or AIDS-related complex. Am J Infect Control (1990) 1.09
Auscultation of the heart by machine and by physicians. JAMA (1967) 1.05
Lymphocyte transformation and macrophage migration inhibition by electrofocused and gel-filtered fractions of group A streptococcal filtrate. Cell Immunol (1974) 1.01
Patients' percentions of physicians' behavior: determinants of patient commitment to the therapeutic relationship. J Community Health (1979) 0.99
Precipitating antibody to group A streptococcal polysaccharide in humans. J Immunol (1971) 0.96
Long bone erosions and ascites in progressive systemic sclerosis (scleroderma). J Rheumatol (1982) 0.96
Costochondritis. A prospective analysis in an emergency department setting. Arch Intern Med (1994) 0.96
Suppression of adjuvant arthritis by a new cytotoxic compound, rubidomycin. Ann Rheum Dis (1969) 0.95
Type II benign osteopetrosis (Albers-Schönberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations. Calcif Tissue Int (2003) 0.93
Mechanisms of osteoclast dysfunction in human osteopetrosis: abnormal osteoclastogenesis and lack of osteoclast-specific adhesion structures. J Bone Miner Res (1999) 0.92
Functional and immunological characterization of the stimulation of human lymphocytes with a mitogen from group A streptococci (SM). Cell Immunol (1982) 0.92
High lymphocyte transformation with non-haemolytic streptococcal product. Nature (1968) 0.91
The risk of bacterial endocarditis during antirheumatic prophylaxis. JAMA (1967) 0.90
Effect of valvular surgery on antibody to the group A streptococcal carbohydrate. Circulation (1974) 0.90
Lymphocyte transformation with streptolysin S preparations and inhibition of streptolysin S by serum in rheumatic fever and other rheumatic diseases. J Lab Clin Med (1972) 0.90
Induction of Ia-like antigens by a group A streptococcal product with mitogenic activity. Transplant Proc (1981) 0.87
Isolation by electrofocusing of two lymphocyte mitogens produced by Staphylococcus aureus. Infect Immun (1972) 0.87
Release of macrophage migration inhibitory factor(s) from lymphocytes stimulated by streptococcal preparations. Cell Immunol (1973) 0.86
Lymphocyte 5'-nucleotidase: absence of detectable protein in chronic lymphocytic leukemia. Blood (1977) 0.86
S. aureus nasal carriage among homosexual men with and without HIV infection. Am J Infect Control (1991) 0.86
Immunosuppression by procarbazine. I. Sites of action of the drug and effect on adjuvant arthritis and circulating antibody responses. Cell Immunol (1972) 0.85
Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines. Eur J Cancer (2001) 0.83
Apparent cure of a newborn with malignant osteopetrosis using prednisone therapy. J Bone Miner Res (2001) 0.82
Association of intermediate osteopetrosis with poikiloderma. J Bone Miner Res (1999) 0.82
Inhibition of rat adjuvant arthritis by a new immunosuppressive agent rubidomycin. Experientia (1968) 0.82
Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood. Bone (2000) 0.81
Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in normal and chronic lymphocytic leukemia lymphocytes. Cancer Res (1976) 0.81
Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene. J Bone Miner Res (1998) 0.80
Poststreptococcal diseases: pathogenetic aspects of rheumatic fever and acute poststreptococcal glomerulonephritis. Pathobiol Annu (1978) 0.79
Suppression of adjuvant disease by bacterial extracellular products. Ann Rheum Dis (1972) 0.78
The role of the thymus during the induction of tolerance of a thymus-dependent antigen. J Immunol (1973) 0.78
Experimental streptococcal infections in baboons. Transplant Proc (1969) 0.78
Adenosine and adenosine analogues are more toxic to chronic lymphocytic leukemia than to normal lymphocytes. Blood (1983) 0.77
Osteoclast isolation: new developments and methods. J Bone Miner Res (1999) 0.77
A novel calcium sensor stimulating inositol phosphate formation and [Ca2+]i signaling expressed by GCT23 osteoclast-like cells. Proc Assoc Am Physicians (1999) 0.77
Primary Mycobacterium avium complex septic arthritis in a patient with AIDS. Clin Infect Dis (1995) 0.77
Improvement in CD4 lymphocyte count in HIV-Reiter's syndrome after treatment with sulfasalazine. J Rheumatol (1994) 0.76
Interleukin 6 is not necessary for STAT3 phosphorylation and myocardial hypertrophy following short term beta-adrenergic stimulation. Adv Med Sci (2012) 0.76
Eighteenth rheumatism review. Review of American and English literature for the years 1965 and 1966. Arthritis Rheum (1968) 0.76
In vivo and in vitro immunomodulatory ability of streptococcal mitogen: effects on adjuvant disease in the rat; on homograft rejection in the mouse; and on the appearance of Ia antigens on human T lymphocytes. Drugs Exp Clin Res (1985) 0.76
Hydroxychloroquine in systemic lupus erythematosus. N Engl J Med (1991) 0.75
Effect of thoracic duct drainage on the primary and secondary immune responses in rats. Induction of immunological tolerance. Immunology (1972) 0.75
Attempted prevention of arteriolar lesions in accelerated rat hypertension by immunosuppression. Br J Exp Pathol (1970) 0.75
Immunosuppressive activity of BCG: effects of adjuvant disease, lymphocyte subpopulations, and homing of thoracic duct cells in rats. Infect Immun (1979) 0.75
A pilot study using a staph protein A column (Prosorba) to treat refractory rheumatoid arthritis. J Rheumatol (1999) 0.75
Aspirin on trial. Nature (1993) 0.75
In vivo and in vitro antiinflammatory and immunoregulating properties of streptococcal mitogen: effects on adjuvant disease in the rat, on homograft rejection in the mouse, and on the appearance of Ia antigens on human T lymphocytes. Agents Actions (1986) 0.75
Growth factor production after polytetrafluoroethylene and vein arterial grafting: an experimental study. J Vasc Surg (1996) 0.75
[Biological significance of the hypercupremia in pregnancy]. Riv Ital Ginecol (1975) 0.75
Environment and heredity in rheumatic fever. N Engl J Med (1968) 0.75
The medical Babel. Letters (never sent) to a student nurse, young doctors, assorted hospital people. Hosp Pract (Off Ed) (1986) 0.75
Of man's heart valves and strep's cell walls. Ann Intern Med (1967) 0.75
An immigrant doctor. Perspect Biol Med (1983) 0.75
Appearance of Ia antigens on T lymphocytes stimulated by streptococcal mitogen as an in vitro model of autoimmunity. Int J Tissue React (1985) 0.75
Macrophage function during the development of adjuvant disease. Agents Actions (1990) 0.75
Proceedings: In vivo mechanisms of BCG immunosuppression. Arthritis Rheum (1975) 0.75
Reversible cardiogenic shock in a patient with lupus myocarditis. J Rheumatol (1993) 0.75
A model for rheumatic carditis? Ann Intern Med (1967) 0.75
Modulation of idiotypic and antiidiotypic immunoglobulin G responses in an alloimmune thrombocytopenic patient associated with extracorporeal protein A immunoadsorption. Artif Organs (1996) 0.75
Should adults with rheumatic heart disease be kept on continuous penicillin prophylaxis? Am J Cardiol (1966) 0.75
Prevention of rheumatic fever, with or without vaccines. Arch Inst Cardiol Mex (1978) 0.75
[Rheumatic fever, the idea of progress and the circularity of time]. Recenti Prog Med (1991) 0.75
[The phenomenon of transformation of the lymphocyte. Technic and significance]. Minerva Med (1965) 0.75
The anomalous capping behavior of chronic lymphocytic leukemia lymphocytes: studies with an antilymphocyte antiserum. Clin Immunol Immunopathol (1978) 0.75
Pharmacological modulation of rat monocytes: in vivo effects on Ia expression and interleukin-1 production. Agents Actions (1991) 0.75
Association of anti-platelet IgG antibody levels with response to extracorporeal protein A/silica immunoadsorption in ITP patients. Am J Hematol (1995) 0.75
Inhibitory effect of sera from rheumatoid arthritis patients and enhancing effect of levamisole on total E-rosette levels of lymphoid cells from normal and RA subjects. Int J Tissue React (1984) 0.75
Impaired lymphocyte transformation and capping in autoimmune thrombocytopenic purpura. Blood (1979) 0.75
Recent advances in the diagnosis and in the prevention of rheumatic fever. Bol Asoc Med P R (1977) 0.75
Prevention of bacterial endocarditis. Conn Med (1983) 0.75